Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck

Oral Oncology

Volumn 42, Issue 7, 2006, Pages 691-697

  Bas, Murat ^a   Bier, Henning ^a   Schirlau, Kerstin ^a   Friebe Hoffmann, Ulrike ^a   Scheckenbach, Kathrin ^a   Balz, Vera ^a   Whiteside, Theresa L ^b   Hoffmann, Thomas K ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Cancer immunology; Gamma delta T cells; Squamous cell carcinoma of the head and neck

Indexed keywords

LIPOCORTIN 5;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CD3+ T CELL; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; PROTEIN BINDING; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; T LYMPHOCYTE DELTA; T LYMPHOCYTE GAMMA; T LYMPHOCYTE SUBPOPULATION;

AGED; ANTIGENS, CD3; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PALLIATIVE CARE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 33746224330     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.11.008     Document Type: Article

References (30)

1. Whiteside T.L. Tumor-induced death of immune cells: its mechanisms and consequences. Semin Cancer Biol 12 (2002) 43-50
2. Whiteside T.L. 22. Immune responses to malignancies. J Allergy Clin Immunol 111 (2003) S677-S686
3. Hoffmann T.K., Bier H., and Whiteside T.L. Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck. Cancer Immunol Immunother (2004)
4. Kuss I., Hathaway B., Ferris R.L., Gooding W., and Whiteside T.L. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 10 (2004) 3755-3762
5. Hoffmann T.K., Dworacki G., Tsukihiro T., Meidenbauer N., Gooding W., Johnson J.T., et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8 (2002) 2553-2562
6. Parkin J., and Cohen B. An overview of the immune system. Lancet 357 (2001) 1777-1789
7. Kabelitz D., Glatzel A., and Wesch D. Antigen recognition by human gamma delta T lymphocytes. Int Arch Allergy Immunol 122 (2000) 1-7
8. Falini B., Flenghi L., Pileri S., Pelicci P., Fagioli M., Martelli M.F., et al. Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol 143 (1989) 2480-2488
9. Kabelitz D. Function and specificity of human gamma/delta-positive T cells. Crit Rev Immunol 11 (1992) 281-303
10. Ensslin A.S., and Formby B. Comparison of cytolytic and proliferative activities of human gamma delta and alpha beta T cells from peripheral blood against various human tumor cell lines. J Natl Cancer Inst 83 (1991) 1564-1569
11. Kabelitz D. Function and specificity of human gamma/delta-positive T cells. Crit Rev Immunol 11 (1992) 281-303
12. Skeen M.J., and Ziegler H.K. Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection. J Exp Med 178 (1993) 971-984
13. Lopez R.D. Human gamma delta-T cells in adoptive immunotherapy of malignant and infectious diseases. Immunol Res 26 (2002) 207-221
14. Hoffmann T.K., Muller-Berghaus J., Ferris R.L., Johnson J.T., Storkus W.J., and Whiteside T.L. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck. Clin Cancer Res 8 (2002) 1787-1793
15. Hoffmann T.K., Dworacki G., Tsukihiro T., Meidenbauer N., Gooding W., Johnson J.T., et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8 (2002) 2553-2562
16. Bank I., DePinho R.A., Brenner M.B., Cassimeris J., Alt F.W., and Chess L. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 322 (1986) 179-181
17. Brenner M.B., McLean J., Scheft H., Riberdy J., Ang S.L., Seidman J.G., et al. Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes. Nature 325 (1987) 689-694
18. Maziarz R.T., Groh V., Prendergast M., Fabbi M., Strominger J.L., and Burakoff S.J. Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing. Int J Cancer 48 (1991) 142-147
19. Ferrarini M., Heltai S., Pupa S.M., Mernard S., and Zocchi R. Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gamma delta (+) T-cell receptors. J Natl Cancer Inst 88 (1996) 436-441
20. Laad A.D., Thomas M.L., Fakih A.R., and Chiplunkar S.V. Human gamma delta T cells recognize heat shock protein-60 on oral tumor cells. Int J Cancer 80 (1999) 709-714
21. Thomas M.L., Samant U.C., Deshpande R.K., and Chiplunkar S.V. Gamma delta T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysis. Cancer Immunol Immunother 48 (2000) 653-659
22. Miescher S., Schreyer M., Barras C., Capasso P., and von Fliedner V. Sparse distribution of gamma/delta T lymphocytes around human epithelial tumors predominantly infiltrated by primed/memory T cells. Cancer Immunol Immunother 32 (1990) 81-87
23. Kobayashi H., Tanaka Y., Yagi J., Toma H., and Uchiyama T. Gamma/delta T cells provide innate immunity against renal cell carcinoma. Cancer Immunol Immunother 50 (2001) 115-124
24. Argentati K., Re F., Serresi S., Tucci M.G., Bartozzi B., Bernardini G., et al. Reduced number and impaired function of circulating gamma delta T cells in patients with cutaneous primary melanoma. J Invest Dermatol 120 (2003) 829-834
25. Ferrer M., Izeboud T., Ferreira C.G., Span S.W., Giaccone G., and Kruyt F.A. Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner. Exp Cell Res 286 (2003) 381-395
26. Kosmider B., Osiecka R., Ciesielska E., Szmigiero L., Zyner E., and Ochocki J. Induction of apoptosis and necrosis in lymphocytes by the cis-Pt (II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat Res 558 (2004) 169-179
27. Perry G.A., Jackson J.D., and Talmadge J.E. Effects of a multidrug chemotherapy regimen on the thymus. Thymus 23 (1994) 39-51
28. Ito M., Kojiro N., Ikeda T., Ito T., Funada J., and Kokubu T. Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis. Chest 102 (1992) 195-197
29. Kabelitz D., and Wesselborg S. Life and death of a superantigen-reactive human CD4+ T cell clone: staphylococcal enterotoxins induce death by apoptosis but simultaneously trigger a proliferative response in the presence of HLA-DR+ antigen-presenting cells. Int Immunol 4 (1992) 1381-1388
30. McCredie J.A., MacDonald H.R., and Wood S.B. Effect of operation and radiotherapy on antibody-dependent cellular cytotoxicity. Cancer 44 (1979) 99-105